Hepatobiliary Communications

Open access

ISSN: 3117-8162

Hepatobiliary Communications

Open access

Editor-in-Chief

Yu Chen

Editorial Board

Hepatobiliary Communications is an international, peer-reviewed, open-access journal dedicated to advancing the prevention, diagnosis, treatment, and translational understanding of liver and biliary ...

Hepatobiliary Communications is an international, peer-reviewed, open-access journal dedicated to advancing the prevention, diagnosis, treatment, and translational understanding of liver and biliary diseases. Hepatobiliary Communications publishes high-quality Original Articles, Reviews, Expert Opinions/Perspectives, Short Communications/Brief Reports, and Letters to the Editor across (but not limited to) the following topics:

  • Viral hepatitis

  • Metabolic-associated fatty liver disease

  • Alcohol-related liver disease

  • Drug-induced liver injury

  • Autoimmune liver diseases

  • Cholestatic liver disease and biliary tract disorders

  • Hepatocellular carcinoma and biliary tract malignancies

  • Cirrhosis and its complications

  • Acute liver failure

  • Acute-on-chronic liver failure

  • Liver transplantation

  • Experimental and translational hepatology

  • Epidemiology and population health in liver diseases

  • Innovative and emerging diagnostic approaches

  • Artificial intelligence and digital hepatology

Editorial Board

Society affiliation

The Translational Hepatology Institute at Capital Medical University (THI-CMU), established in 2014, is the first translational medicine institute of Capital Medical University. Supported by the strengths of Capital Medical University’s School of Basic Medical Sciences, School of Biomedical Engineering, School of Pharmaceut...

The Translational Hepatology Institute at Capital Medical University (THI-CMU), established in 2014, is the first translational medicine institute of Capital Medical University. Supported by the strengths of Capital Medical University’s School of Basic Medical Sciences, School of Biomedical Engineering, School of Pharmaceutical Sciences, and affiliated

The iGandan Platform is a leading healthcare platform focused on hepatobiliary healthcare. iGandan is committed to improving healthcare delivery and advancing academic collaboration in hepatology. The platform connects physicians and patients, while also providing governments, enterprises, and institutions with services including policy consultation, information research, education and training, database development, and academic communication.

Hepatobiliary Communications: Advancing hepatobiliary science and medicine

The medicinal effect of ulinastatin in various liver diseases

Dynamic Changes in Visceral Fat Density and Skeletal Muscle Index Predict New-onset Decompensation in Chronic Hepatitis B-Related Cirrhosis

View all ScienceDirect

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.